SLC16A1 and cancer: Comparison of RNAseq datasets from TCGA and the Cancer Cell Line Encyclopedia (CCLE) with The Genotype-Tissue Expression (GTEx) portal revealed that ~20–25% of PDACs exhibit increased expression of SLC16A1, the gene encoding MCT1, a mediator of 3BP activity.